Innate Pharma SA (IPHA)

2.37 -0.65 (-21.52%) USD  |  NASDAQ  |  Dec 16, 16:00
2.32 -0.05 (-2.11%) After-Hours: 05:13
More

Innate Pharma EV to Revenues

EV to Revenues Chart

View EV to Revenues for IPHA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA Upgrade
Genfit SA Upgrade
Inventiva SA Upgrade
Nanobiotix SA Upgrade

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade